Fig. 1From: Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy for locally advanced rectal cancer: 3-year survival from a phase 2 studyKaplan–Meier curves for 3-year disease-free survival. CI, confidence interval; NR, not reachedBack to article page